STAA Q3 2017 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$871M

Q3 2017 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$23M+17.1% YoY

Gross Profit

$17M71.8% margin

Operating Income

$1M4.4% margin

Net Income

$1M5.0% margin

EPS (Diluted)

$0.03

QoQ Revenue Growth

+7.0%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$3M

Stock-Based Comp.

$807,000

Balance Sheet

Total Assets

$73M

Total Liabilities

$32M

Stockholders' Equity

$41M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$20M	+17.1%
Gross Profit	$17M	$15M	+13.3%
Operating Income	$1M	-$2M	+160.8%
Net Income	$1M	-$2M	+166.0%

Revenue Segments

Implantable Collamer Lenses

$18M77%

Intraocular Lenses

$4M17%

Other Surgical Products

$1M6%

Geographic Segments

Other Countries

$10M42%

CHINA

$7M31%

JAPAN

$5M20%

UNITED STATES

$2M8%